Recompensation of Decompensated Hepatitis B Cirrhosis: Current Status and Challenges

Liver-function decompensation or hepatocellular carcinoma (HCC) gradually appears after chronic hepatitis B progresses to cirrhosis. Effective antiviral treatment can significantly improve the long-term prognosis of decompensated patients, and some patients present recompensation of decompensated he...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Hong, Wang, Qi, Luo, Changling, Liu, Ligai, Xie, Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527887/
https://www.ncbi.nlm.nih.gov/pubmed/33029534
http://dx.doi.org/10.1155/2020/9609731
_version_ 1783589149507321856
author Zhao, Hong
Wang, Qi
Luo, Changling
Liu, Ligai
Xie, Wen
author_facet Zhao, Hong
Wang, Qi
Luo, Changling
Liu, Ligai
Xie, Wen
author_sort Zhao, Hong
collection PubMed
description Liver-function decompensation or hepatocellular carcinoma (HCC) gradually appears after chronic hepatitis B progresses to cirrhosis. Effective antiviral treatment can significantly improve the long-term prognosis of decompensated patients, and some patients present recompensation of decompensated hepatitis B cirrhosis. At present, there are limited research data on the recompensation of decompensated hepatitis B cirrhosis. There is still controversy regarding the evaluation time, evaluation indicators, influencing factors, and long-term prognosis of recompensation.
format Online
Article
Text
id pubmed-7527887
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-75278872020-10-06 Recompensation of Decompensated Hepatitis B Cirrhosis: Current Status and Challenges Zhao, Hong Wang, Qi Luo, Changling Liu, Ligai Xie, Wen Biomed Res Int Review Article Liver-function decompensation or hepatocellular carcinoma (HCC) gradually appears after chronic hepatitis B progresses to cirrhosis. Effective antiviral treatment can significantly improve the long-term prognosis of decompensated patients, and some patients present recompensation of decompensated hepatitis B cirrhosis. At present, there are limited research data on the recompensation of decompensated hepatitis B cirrhosis. There is still controversy regarding the evaluation time, evaluation indicators, influencing factors, and long-term prognosis of recompensation. Hindawi 2020-09-21 /pmc/articles/PMC7527887/ /pubmed/33029534 http://dx.doi.org/10.1155/2020/9609731 Text en Copyright © 2020 Hong Zhao et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Zhao, Hong
Wang, Qi
Luo, Changling
Liu, Ligai
Xie, Wen
Recompensation of Decompensated Hepatitis B Cirrhosis: Current Status and Challenges
title Recompensation of Decompensated Hepatitis B Cirrhosis: Current Status and Challenges
title_full Recompensation of Decompensated Hepatitis B Cirrhosis: Current Status and Challenges
title_fullStr Recompensation of Decompensated Hepatitis B Cirrhosis: Current Status and Challenges
title_full_unstemmed Recompensation of Decompensated Hepatitis B Cirrhosis: Current Status and Challenges
title_short Recompensation of Decompensated Hepatitis B Cirrhosis: Current Status and Challenges
title_sort recompensation of decompensated hepatitis b cirrhosis: current status and challenges
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527887/
https://www.ncbi.nlm.nih.gov/pubmed/33029534
http://dx.doi.org/10.1155/2020/9609731
work_keys_str_mv AT zhaohong recompensationofdecompensatedhepatitisbcirrhosiscurrentstatusandchallenges
AT wangqi recompensationofdecompensatedhepatitisbcirrhosiscurrentstatusandchallenges
AT luochangling recompensationofdecompensatedhepatitisbcirrhosiscurrentstatusandchallenges
AT liuligai recompensationofdecompensatedhepatitisbcirrhosiscurrentstatusandchallenges
AT xiewen recompensationofdecompensatedhepatitisbcirrhosiscurrentstatusandchallenges

Ejemplares similares